practical range I'm looking at, with a time frame of half a...

practical range I'm looking at, with a time frame of half a year, by mid-July 2023:
Higher Limit: $0.65
Lower Limit: $0.30

Technical concerns:

1. rounded sentimental levels from the past years, representing the high and low extremes
2. not actively traded, volume too low even on great announcements to value the charts with much significance. From trading's perspective, no sufficient amount of holders sit on huge profit or loss to justify aggregated sell actions and subsequently cause long-lasting down trend.
3. positive sentiment resulted from the listed below should provide excitement lasting for a year or so, however by mid 2023 not expecting any developments to push the share price above $0.65 and stay there for an extended period (e.g., a couple of months)

• quarterly sales expectations Straite+ and Remplir
• potential JnJ deal or further collaboration on ATI
• potential Striate+ deal in other fields, e.g, tendon, nerve

1. not an EOFY tax selling target (yet at least, and no signs to become one), less vunerable to economic downturn (current market worry)
2. without institution shareholders onboard, share price actions will remain sluggish

Fundamental concerns:

1. cash on hand to fund further trials in following years. Sales revenue starts flow in, albeit small, provides certainty and strengthen the company's position as a business
2. commencialisation just began, at best it take years to reach prime, with limited success in the first year, i.e., not an investment for income grade stock for years to come.